Literature DB >> 21816823

Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Ruma Mukerjee1, J Robert Chang, Luis Del Valle, Asen Bagashev, Monika M Gayed, Randolph B Lyde, Brian J Hawkins, Eugen Brailoiu, Eric Cohen, Chris Power, S Ausim Azizi, Benjamin B Gelman, Bassel E Sawaya.   

Abstract

Studies have shown that HIV-infected patients develop neurocognitive disorders characterized by neuronal dysfunction. The lack of productive infection of neurons by HIV suggests that viral and cellular proteins, with neurotoxic activities, released from HIV-1-infected target cells can cause this neuronal deregulation. The viral protein R (Vpr), a protein encoded by HIV-1, has been shown to alter the expression of various important cytokines and inflammatory proteins in infected and uninfected cells; however the mechanisms involved remain unclear. Using a human neuronal cell line, we found that Vpr can be taken up by neurons causing: (i) deregulation of calcium homeostasis, (ii) endoplasmic reticulum-calcium release, (iii) activation of the oxidative stress pathway, (iv) mitochondrial dysfunction and v- synaptic retraction. In search for the cellular factors involved, we performed microRNAs and gene array assays using human neurons (primary cultures or cell line, SH-SY5Y) that we treated with recombinant Vpr proteins. Interestingly, Vpr deregulates the levels of several microRNAs (e.g. miR-34a) and their target genes (e.g. CREB), which could lead to neuronal dysfunctions. Therefore, we conclude that Vpr plays a major role in neuronal dysfunction through deregulating microRNAs and their target genes, a phenomenon that could lead to the development of neurocognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816823      PMCID: PMC3186354          DOI: 10.1074/jbc.M111.241547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Small non-coding RNAs as novel therapeutics.

Authors:  M Rossbach
Journal:  Curr Mol Med       Date:  2010-06       Impact factor: 2.222

2.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

3.  Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons.

Authors:  Emmanuelle N Sabbah; Bernard P Roques
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

4.  HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.

Authors:  Gareth J Jones; Nicola L Barsby; Eric A Cohen; Janet Holden; Kim Harris; Peter Dickie; Jack Jhamandas; Christopher Power
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

Review 5.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

Review 6.  Mechanisms of neuronal injury and death in HIV-1 associated dementia.

Authors:  Marcus Kaul; Stuart A Lipton
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

Review 7.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01

8.  Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.

Authors:  Rulun Zhou; Peixiong Yuan; Yun Wang; Joshua G Hunsberger; Abdel Elkahloun; Yanling Wei; Patricia Damschroder-Williams; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

9.  MicroRNA expression in Alzheimer blood mononuclear cells.

Authors:  Hyman M Schipper; Olivier C Maes; Howard M Chertkow; Eugenia Wang
Journal:  Gene Regul Syst Bio       Date:  2007-12-20

10.  Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

Authors:  Elodie Roggli; Aurore Britan; Sonia Gattesco; Nathalie Lin-Marq; Amar Abderrahmani; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more
  25 in total

Review 1.  Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.

Authors:  A Sami Saribas; Pascale Coric; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2018-11-02       Impact factor: 6.384

Review 2.  MicroRNAs and HIV-1: complex interactions.

Authors:  Zachary Klase; Laurent Houzet; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

Review 3.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  HIV-1 Tat- and Vpr-responsive microRNAs of neuronal cells.

Authors:  Kenneth W Witwer
Journal:  J Biol Chem       Date:  2014-01-31       Impact factor: 5.157

5.  Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.

Authors:  Will Dampier; Gregory C Antell; Benjamas Aiamkitsumrit; Michael R Nonnemacher; Jeffrey M Jacobson; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Tony James; Kathryn N Devlin; Tania Giovannetti; David J Libon; Zsofia Szep; Garth D Ehrlich; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

Review 6.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

7.  HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.

Authors:  Ying Wang; Maryline Santerre; Italo Tempera; Kayla Martin; Ruma Mukerjee; Bassel E Sawaya
Journal:  Neuropharmacology       Date:  2017-02-14       Impact factor: 5.250

Review 8.  Fate of microglia during HIV-1 infection: From activation to senescence?

Authors:  Natalie C Chen; Andrea T Partridge; Christian Sell; Claudio Torres; Julio Martín-García
Journal:  Glia       Date:  2016-11-26       Impact factor: 7.452

9.  Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.

Authors:  Andrew J Levine; Austin Quach; David J Moore; Cristian L Achim; Virawudh Soontornniyomkij; Eliezer Masliah; Elyse J Singer; Benjamin Gelman; Natasha Nemanim; Steve Horvath
Journal:  J Neurovirol       Date:  2015-12-21       Impact factor: 2.643

Review 10.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.